Bismuth Subsalicylate Suspension With a Lead-Free Three-Gum System

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bismuth subsalicylate formulations rely on magnesium aluminum silicate, which may contain trace amounts of lead, and struggle to maintain suspension without sedimentation, necessitating a lead-free alternative that effectively keeps bismuth subsalicylate in suspension.

Innovation Solution

A three-gum system comprising bismuth subsalicylate, microcrystalline cellulose, xanthan gum, and excipients like carboxymethyl cellulose or hydroxyethyl cellulose is used to suspend bismuth subsalicylate, eliminating the need for magnesium aluminum silicate and maintaining suspension without sedimentation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If magnesium aluminum silicate is used to suspend bismuth subsalicylate, then suspension stability is improved, but lead contamination risk increases

Engineering Contradiction:
Improvesuspension stabilityVSAvoidlead contamination
Core Design Contradiction:
Stability of the object's compositionVSObject-affected harmful factors

Solution Approach 1:

The patent removes magnesium aluminum silicate (the harmful component containing lead) from the formulation and replaces it with an alternative gum system consisting of xanthan gum, carboxymethyl cellulose, and hydroxyethyl cellulose, thereby eliminating lead contamination while maintaining suspension stability

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs a composite gum system combining three different gums (xanthan gum, carboxymethyl cellulose, and hydroxyethyl cellulose) to achieve the suspension stability previously provided by magnesium aluminum silicate, without the associated lead contamination risk

Inventive Principle:
Principle #40Composite materials

2Stability of the object's composition

If magnesium aluminum silicate is used to suspend bismuth subsalicylate, then sedimentation prevention is improved, but formulation complexity increases

Engineering Contradiction:
Improvesedimentation preventionVSAvoidformulation complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent divides the suspension stabilization function among three separate gum components (xanthan gum, carboxymethyl cellulose, and hydroxyethyl cellulose), each contributing different properties that collectively prevent sedimentation, replacing the single-component magnesium aluminum silicate system

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the chemical composition parameters of the gum system from magnesium aluminum silicate to a combination of polysaccharide-based gums, altering the mechanism of suspension stabilization while achieving equivalent or superior sedimentation prevention

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The three-gum system effectively prevents sedimentation of bismuth subsalicylate, ensuring stable suspension and reducing lead content, while maintaining suitable viscosity and pH for oral administration.

Implementation Method 1

microcrystalline cellulose, xanthan gum, and an excipient selected from the group consisting of: carboxymethyl cellulose (CMC), carageenan, and hydroxyethyl cellulose (HEC), or combinations thereof

Methodology Applied
Scientific EffectViscosity: Viscometer

Data Source

PatentUS12576092B2Pharmaceutical suspensions for bismuth subsalicylates
Publication Date: 2026.03.17 PERRIGO L CO
  • US12576092B2 patent drawing
  • US12576092B2 patent drawing
  • US12576092B2 patent drawing

AI summary

The invention is directed to pharmaceutical compositions for suspending bismuth subsalicylate and methods of use thereof. Formulations of the present invention include at least three-gum systems to prevent the settling out of heavy particles in solution and do not include magnesium aluminum silicate. The pharmaceutical compositions may be used to treat gastrointestinal disorders.